Feedback / Questions
etrolizumab (RG7413) - Roche
Etrolizumab: Regulatory submissions in US/EU for Crohn's disease in 2022
(Roche)
-
Apr 22, 2020 -
Q1 2020 Results
BLA • European regulatory
•
Crohn's Disease • Immunology • Inflammation • Inflammatory Bowel Disease
https://www.roche.com/dam/jcr:f5b0e8e3-66fb-4155-85ff-ec1b012fb46c/en/irp200422.pdf
Apr 22, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious